Clinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forward

ANTONIO LOPEZ BELTRAN2026-01-292026-01-29202310.1080/14712598.2023.22013712-s2.0-85152356279https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/36279Clinical BiochemistryDrug DiscoveryPharmacologyClinical utility of checkpoint inhibitors against metastatic bladder cancer: overcoming challenges to find a way forwardreview article